An academic cell and gene therapy centre in the Texas Medical Center, run jointly by Houston Methodist, Baylor College of Medicine and Texas Children's Hospital.
The Center for Cell and Gene Therapy is an academic programme in the Texas Medical Center in Houston, described on the Houston Methodist website as a collaboration between Houston Methodist Hospital, Baylor College of Medicine and Texas Children's Hospital. It is a hospital and university programme rather than a private clinic, and its stated purpose is to develop cellular and genetic treatments and to get patients access to them, including through clinical trials.
Two areas of treatment are described. The first is bone marrow and stem cell transplantation, with separate adult and paediatric transplant units; the adult unit is for people whose immune systems are suppressed by treatment and the site notes it has an advanced air filtration system. The second is chimeric antigen receptor T-cell therapy (CAR-T), which the site describes as an immunotherapy in which a patient's own T cells are genetically modified to recognise and attack cancer cells, used mainly for blood cancers.
Alongside treatment the centre runs laboratory and translational research, with stated interests that extend beyond cancer to include human immunodeficiency virus (HIV) infection, cardiovascular disease and autoimmune disease. Those wider areas are presented as research rather than as treatments currently on offer, and a reader should not take them as services available to walk-in patients.
This is an established, regulated academic cell therapy programme accessed by oncology referral, not a private regenerative medicine clinic, and it does not offer cell injections for joints, ageing or general wellness. The pages reviewed do not name individual physicians, do not state the centre's accreditation, do not give a founding year and say nothing about cost, insurance or interpreting services.
The treatments described are for blood cancers; other conditions named on the site are research interests rather than established services.
The site describes blood stem cell transplantation and chimeric antigen receptor T-cell therapy, in which the patient's own T cells are genetically modified to target cancer cells.
No individual clinician is named on the pages reviewed; the site describes the centre as a collaboration between experts at three institutions, so a prospective patient would need to ask who would lead their care.
The centre is based in the Texas Medical Center in Houston and occupies clinical and laboratory space across the collaborating institutions. The site describes separate paediatric and adult bone marrow and stem cell transplant units, an adult unit with advanced air filtration for patients whose immunity is suppressed, a family-centred adult transplant unit with activity and entertainment space for long admissions, and laboratory space for basic and translational research.
The site publishes no prices and makes no statement about insurance cover or financial assistance. Transplantation and approved cell therapies of this type are normally delivered on specialist referral and billed to insurance, and clinical trial participation has its own funding arrangements, but none of this is set out on the pages reviewed.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.